Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 2015

View Archived Issues

Nucleic acid antibody prophylaxis as an antiviral immunotherapy for dengue

FDA OOPD awards grant to support development of ADXS-HPV in throat cancer

PeptiDream and Sanofi establish peptide discovery collaboration

RaQualia selects RQ-00433412 for preclinical development in cancer cachexia

STAT2 regulates mitochondrial fission

Baxalta files for U.S. approval of 20% immunoglobulin subcutaneous

XenoPort reports phase II study data for XP-23829

P2X7R antagonist reduces neuronal death in epilepsy model

Amicus Therapeutics to submit NDA for migalastat for Fabry disease

Teijin Pharma and Amgen report ROR-gamma antagonists

BARDA funding awarded to Crucell Holland to accelerate Ebola vaccine program

Laboratoire Biodim discloses dltA inhibitors

Glenmark Pharmaceuticals' GBR-1302 to enter phase I trials

Ono Pharmaceutical describes EP2 agonists

Jiangsu Ascentage Biomed Development reports ALK inhibitors

Andexanet alfa achieves rapid and sustained reversal of rivaroxaban in phase III trial

Sichuan Haisco Pharmaceutical reports phosphoramidate antivirals

Mylan initiates offer for Perrigo shares, Perrigo tells shareholders to wait

RepliCel starts phase I trial of autologous fibroblast therapy RCS-01

AZTherapies initiates phase III study of ALZT-OP1 for early Alzheimer's disease

Seegene and BD Life Sciences collaborate to develop multiplex molecular diagnostic assays

Bionomics reports data from phase I trial of BNC-210 for anxiety and depression

Depomed urges shareholders to reject Horizon Pharma's unsolicited exchange offer

Hemostemix signs strategic alliance agreement with Hemostemix Asia for ACP-01

Cotranstplantation of islets and dental pulp stem cells improves survival in diabetic mice

ALCAM mediates late kidney complications of diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...